Free Trial

Scienture Q1 2024 Earnings Report

$7.58 -0.55 (-6.77%)
(As of 12/20/2024 05:16 PM ET)

Scienture EPS Results

Actual EPS
-$6.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Scienture Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Scienture Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)

Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.

Click here to see Dan's full warning to the public.
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Scienture? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Scienture and other key companies, straight to your email.

About Scienture

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

View Scienture Profile

More Earnings Resources from MarketBeat

Upcoming Earnings